Fundz

ESTEVE acquires Regis Technologies for U.S. expansion

Jul 31, 2025

Acquiring Company

Esteve

Acquired Company

Regis Technologies

BarcelonaChicagoManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnology

Description

ESTEVE has acquired Regis Technologies, enhancing its contract development and manufacturing capacity in the U.S. This acquisition allows ESTEVE to establish a physical presence in the U.S. and expand its offerings for innovative pharmaceutical active ingredients. The move is part of ESTEVE's commitment to improving lives through enhanced CDMO capabilities.

Who to call at Esteve, and when

When Esteve changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Esteve raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Esteve, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Esteve. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Esteve

Location

Barcelona, Catalonia, Spain

About

Esteve is a global pharmaceutical company headquartered in Barcelona, focused on providing solutions for unmet medical needs. With a history dating back to 1929, ESTEVE is committed to improving people's lives through its pharmaceutical products and services.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Esteve makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rodrigo
Senior decision-maker at this company
••••••••@••••••••

See Rodrigo's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Esteve's next move

Learn about Strategic plan

Frequently asked

Who acquired Regis Technologies?

Regis Technologies was acquired by Esteve, based in Barcelona. The deal was reported on July 31, 2025. Esteve is a global pharmaceutical company headquartered in Barcelona, focused on providing solutions for unmet medical needs. Esteve is privately held and operates in Manufacturing.

When did Esteve acquire Regis Technologies?

Esteve's acquisition of Regis Technologies was reported on July 31, 2025. ESTEVE has acquired Regis Technologies, enhancing its contract development and manufacturing capacity in the U.S. This acquisition allows ESTEVE to establish a physical presence in the U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Regis Technologies do?

Regis Technologies partners with pharmaceutical and biotechnology companies to streamline drug development processes. Founded in 1956, it offers a variety of services, including cGMP API manufacturing and analytical development. It is privately held, operating in Manufacturing, and is based in Chicago.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.